Sutent Clinical Trials
Here are the 6 most popular medical studies for sutent
Tyrosine Kinase Inhibitor
Sunitinib for Thymoma
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is testing the safety and effectiveness of sunitinib as a treatment for advanced thymus cancer. Eligible participants must be at least 18 years old and have had at least one previous chemotherapy treatment containing platinum. Sunitinib will be taken once daily for 4 weeks, followed by 2 weeks of rest. This 6-week period will be repeated as long as the tumor does not continue to grow and there are no severe side effects.
Tyrosine Kinase Inhibitor
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
Recruiting1 awardPhase 2
Santa Monica, California
This trial is testing the effects of two drugs, cediranib and sunitinib, on patients with a rare cancer called alveolar soft part sarcoma. The trial will see if either of the drugs help to shrink the tumors, and if so, which drug works better.
Corticosteroid
Maximal Androgen Ablation with Molecular Targeted Therapies for Prostate Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial is for men with prostate cancer that has spread to other parts of the body. You will be given prednisone, abiraterone acetate, sunitinib malate, and dasatinib. These drugs are all FDA-approved, but their use in prostate cancer and in combination with each other is still being researched. Up to 180 patients will be enrolled at MD Anderson.
Popular filter options for sutent trials
Phase 3 Clinical Trials
View 34 phase 3 medical studies.
Kinase Inhibitor
Savolitinib vs Sunitinib for PRCC
Recruiting2 awardsPhase 3
La Jolla, California
This trial is for patients with a certain type of kidney cancer that has spread and cannot be removed by surgery. The goal is to see if a new medication, savolitinib, is better than the current standard of care, sunitinib, and to learn about any side effects.
Clinical Trials With No Placebo
View 34 medical studies that do not have a placebo group.
CDK4/6 Inhibitor
Abemaciclib + Sunitinib for Renal Cell Carcinoma
Recruiting1 awardPhase 1
Hershey, Pennsylvania
This trial is testing the safety of a new combination drug regimen for treating advanced and metastatic renal cell carcinoma. The study will enroll participants in a 3x3 dose escalation study design to determine the maximal tolerated dose of the new drug combination. The study will then enroll additional participants in a dose expansion phase to further evaluate the safety and tolerability of the new drug combination.
Angiotensin II Receptor Blocker
Losartan + Sunitinib for Osteosarcoma
Recruiting1 awardPhase 1
Aurora, Colorado
This trial is testing a combination of two drugs to see what the highest dose is that people can tolerate without serious side effects. Once they find that, they'll test that dose to see if it's effective.
Kinase Inhibitor
Savolitinib vs Sunitinib for PRCC
Recruiting2 awardsPhase 3
La Jolla, California
This trial is for patients with a certain type of kidney cancer that has spread and cannot be removed by surgery. The goal is to see if a new medication, savolitinib, is better than the current standard of care, sunitinib, and to learn about any side effects.
Tyrosine Kinase Inhibitor
Targeted Therapies for Multiple Myeloma, Non-Hodgkin's Lymphoma, and Solid Tumors
Recruiting1 awardPhase 2
Birmingham, Alabama
This trial is studying how well different targeted drugs work in treating patients with cancer that has progressed after other treatments and has a genomic variant that makes the tumor respond to the drug.
View More Sutent Trials
See another 18 many medical studies focused on sutent.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.